GlassScriptPhysician profile
Alandra Greenlee
NPI 1952720930
$15,554.95
in general payments reported to CMS, 2019-2025
17 companies · $3,856 in 2025
The $3,856 reported for 2025 was more than what 91% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $122 · 2021: $1,401 · 2022: $2,875 · 2023: $2,824 · 2024: $4,477 · 2025: $3,856.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,423 · Travel and Lodging: $4,734.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,422.65 |
| Travel and Lodging | $4,734.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $6,900.88 | 2021-2025 | Portfolio, Monkey Rings, Smart28 |
| Stryker Corporation | $4,225.13 | 2020-2025 | Citrefix, Prophecy, Inbone |
| Kerecis Limited | $1,408.81 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Seapearl East, INC | $1,279.01 | 2022-2025 | |
| Integra Lifesciences Corporation | $441.28 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $289.42 | 2021-2025 | Grafix Pl, Oasis, Stravix Pl |
| Treace Medical Concepts, INC. | $253.12 | 2024-2025 | |
| Musculoskeletal Transplant Foundation INC. | $190.14 | 2021 | |
| Extremity Medical | $146.87 | 2025 | |
| Biocomposites INC | $143.18 | 2025 | Stimulan |
| Guard Medical INC. | $113.76 | 2024 | Npseal Large |
| Medshape, INC. | $46.51 | 2023 | Dynanail |
| Abbott Laboratories | $38.43 | 2023-2024 | Freestyle Libre 3 |
| Wright Medical Technology, INC. | $27.36 | 2020 | |
| Bioventus LLC | $18.44 | 2025 | Durolane |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.98 | 2023 | Synjardy, Jardiance |
| Xeris Pharmaceuticals, INC. | $15.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alandra Greenlee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.